{"pageContent": "Introduction: Stereotactic body radiation therapy (SBRT) is considered an effective and safe treatment in patients with low- and intermediate-risk prostate cancer (PC). However, due to a lack of long-term follow-up and late toxicity data, this treatment is not universally accepted. The present study aimed to evaluate outcome and early and late toxicity in a cohort of patients with low- and intermediate-risk PC treated prospectively with linear accelerator (linac)-based SBRT.", "metaData": {"source": "Focal therapy and imaging in prostate and kidney cancer: high-intensity focused ultrasound ablation of small renal tumors\nhttps://pubmed.ncbi.nlm.nih.gov/20380511/"}}